L-765,314
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
benzyl (2S)-4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2-(tert-butylcarbamoyl)piperazine-1-carboxylate
|
|
Identifiers | |
PubChem | CID: 6603904 |
IUPHAR/BPS | 506 |
ChEMBL | CHEMBL19476 |
Chemical data | |
Formula | C27H34N6O5 |
Molecular mass | 522.595 g/mol |
|
|
(what is this?) (verify) |
L-765,314 is a drug which acts as a potent and selective antagonist for the Alpha-1 adrenergic receptor subtype α1B.[1] It has mainly been used to investigate the role of α1B receptors in the regulation of blood pressure.[2][3] The α1B receptor is also thought to have an important role in the brain; however, L-765,314 does not cross the blood–brain barrier.[4]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Pages with broken file links
- Antihypertensive agent stubs
- Alpha blockers
- Phenol ethers
- Quinazolines
- Piperazines
- Amides
- Carbamates